CN109988802B - 一种高效分泌表达人源fgf21蛋白的表达盒及其应用 - Google Patents
一种高效分泌表达人源fgf21蛋白的表达盒及其应用 Download PDFInfo
- Publication number
- CN109988802B CN109988802B CN201711494578.7A CN201711494578A CN109988802B CN 109988802 B CN109988802 B CN 109988802B CN 201711494578 A CN201711494578 A CN 201711494578A CN 109988802 B CN109988802 B CN 109988802B
- Authority
- CN
- China
- Prior art keywords
- protein
- rhfgf21
- host cell
- expression
- bacillus subtilis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 138
- 101000846529 Homo sapiens Fibroblast growth factor 21 Proteins 0.000 title abstract description 6
- 102000056713 human FGF21 Human genes 0.000 title abstract description 6
- 230000003248 secreting effect Effects 0.000 title description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 169
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 143
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 72
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 70
- 108010006519 Molecular Chaperones Proteins 0.000 claims abstract description 11
- 101710089384 Extracellular protease Proteins 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 31
- 239000013604 expression vector Substances 0.000 claims description 15
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 14
- -1 secYEG Proteins 0.000 claims description 14
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 12
- 108010078791 Carrier Proteins Proteins 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 101150059374 secY gene Proteins 0.000 claims description 8
- 101100510832 Bacillus subtilis (strain 168) sipV gene Proteins 0.000 claims description 6
- 101100510833 Bacillus subtilis (strain 168) sipW gene Proteins 0.000 claims description 6
- 108090000376 Fibroblast growth factor 21 Proteins 0.000 claims description 6
- 102000003973 Fibroblast growth factor 21 Human genes 0.000 claims description 6
- 101100095302 Streptococcus gordonii secA1 gene Proteins 0.000 claims description 6
- 101150108659 secA gene Proteins 0.000 claims description 6
- 101150102164 secDF gene Proteins 0.000 claims description 6
- 101150114545 secE gene Proteins 0.000 claims description 6
- 101100052565 Bacillus subtilis (strain 168) yddT gene Proteins 0.000 claims description 5
- 101100170061 Escherichia coli (strain K12) ddpX gene Proteins 0.000 claims description 5
- 101150089353 cdaS gene Proteins 0.000 claims description 4
- 101150099492 dacB gene Proteins 0.000 claims description 4
- 101150112117 nprE gene Proteins 0.000 claims description 4
- 101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 claims description 3
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 241000194108 Bacillus licheniformis Species 0.000 claims description 3
- 101100276167 Bacillus subtilis (strain 168) cwlO gene Proteins 0.000 claims description 3
- 101100460774 Bacillus subtilis (strain 168) nprB gene Proteins 0.000 claims description 3
- 101100049732 Bacillus subtilis (strain 168) wprA gene Proteins 0.000 claims description 3
- 101100433053 Bacillus subtilis (strain 168) ywmC gene Proteins 0.000 claims description 3
- 102000004316 Oxidoreductases Human genes 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 3
- 101150040383 pel2 gene Proteins 0.000 claims description 3
- 101150050446 pelB gene Proteins 0.000 claims description 3
- 108060008226 thioredoxin Proteins 0.000 claims description 3
- 229940094937 thioredoxin Drugs 0.000 claims description 3
- 241000194103 Bacillus pumilus Species 0.000 claims description 2
- 101100068894 Bacillus subtilis (strain 168) glvA gene Proteins 0.000 claims description 2
- 101100376835 Bacillus subtilis (strain 168) yoqM gene Proteins 0.000 claims description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 2
- 101150107068 gsiB gene Proteins 0.000 claims description 2
- 108020005038 Terminator Codon Proteins 0.000 claims 1
- 102000002933 Thioredoxin Human genes 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 230000002018 overexpression Effects 0.000 abstract description 10
- 102000005431 Molecular Chaperones Human genes 0.000 abstract description 5
- 238000013519 translation Methods 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 238000013518 transcription Methods 0.000 abstract description 3
- 230000035897 transcription Effects 0.000 abstract description 3
- 230000012846 protein folding Effects 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 53
- 108020004414 DNA Proteins 0.000 description 29
- 238000000855 fermentation Methods 0.000 description 19
- 230000004151 fermentation Effects 0.000 description 19
- 239000000499 gel Substances 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 18
- 230000028327 secretion Effects 0.000 description 18
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 18
- 239000013598 vector Substances 0.000 description 18
- 102000010911 Enzyme Precursors Human genes 0.000 description 16
- 108010062466 Enzyme Precursors Proteins 0.000 description 16
- 239000013592 cell lysate Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 239000012634 fragment Substances 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229960005091 chloramphenicol Drugs 0.000 description 7
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 238000010276 construction Methods 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 101710168624 Thioredoxin 2 Proteins 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000002158 endotoxin Substances 0.000 description 5
- 229960000268 spectinomycin Drugs 0.000 description 5
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000003209 gene knockout Methods 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 229960002160 maltose Drugs 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- 101150073480 CIS1 gene Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108050001049 Extracellular proteins Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 101100110279 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ATG31 gene Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- BFAKENXZKHGIGE-UHFFFAOYSA-N bis(2,3,5,6-tetrafluoro-4-iodophenyl)diazene Chemical compound FC1=C(C(=C(C(=C1F)I)F)F)N=NC1=C(C(=C(C(=C1F)F)I)F)F BFAKENXZKHGIGE-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012533 medium component Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 101100510829 Bacillus subtilis (strain 168) sipS gene Proteins 0.000 description 2
- 101100510831 Bacillus subtilis (strain 168) sipU gene Proteins 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101000666657 Homo sapiens Rho-related GTP-binding protein RhoQ Proteins 0.000 description 2
- 101000687808 Homo sapiens Suppressor of cytokine signaling 2 Proteins 0.000 description 2
- 101000687855 Homo sapiens Suppressor of cytokine signaling 3 Proteins 0.000 description 2
- 101000652224 Homo sapiens Suppressor of cytokine signaling 5 Proteins 0.000 description 2
- 101000652226 Homo sapiens Suppressor of cytokine signaling 6 Proteins 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 102100038339 Rho-related GTP-binding protein RhoQ Human genes 0.000 description 2
- 102100024784 Suppressor of cytokine signaling 2 Human genes 0.000 description 2
- 102100024283 Suppressor of cytokine signaling 3 Human genes 0.000 description 2
- 102100030523 Suppressor of cytokine signaling 5 Human genes 0.000 description 2
- 102100030530 Suppressor of cytokine signaling 6 Human genes 0.000 description 2
- 102100036407 Thioredoxin Human genes 0.000 description 2
- 102100031083 Uteroglobin Human genes 0.000 description 2
- 108090000203 Uteroglobin Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 101150064416 csp1 gene Proteins 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 230000032895 transmembrane transport Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- DUJGMZAICVPCBJ-VDAHYXPESA-N 4-amino-1-[(1r,4r,5s)-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)C(CO)=C1 DUJGMZAICVPCBJ-VDAHYXPESA-N 0.000 description 1
- FQWUNUXAOHTLLG-ASDGIDEWSA-N 6-[(3s,6s,9s,12r)-3,6-dibenzyl-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]-n-hydroxyhexanamide Chemical compound C([C@H]1C(=O)N2CCC[C@@H]2C(=O)N[C@H](C(N[C@@H](CC=2C=CC=CC=2)C(=O)N1)=O)CCCCCC(=O)NO)C1=CC=CC=C1 FQWUNUXAOHTLLG-ASDGIDEWSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 101100138645 Bacillus licheniformis pelA gene Proteins 0.000 description 1
- 101100332804 Bacillus subtilis (strain 168) efeN gene Proteins 0.000 description 1
- 101100226150 Bacillus subtilis (strain 168) estA gene Proteins 0.000 description 1
- 101100441252 Caenorhabditis elegans csp-2 gene Proteins 0.000 description 1
- 101100222092 Caenorhabditis elegans csp-3 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 101100192384 Escherichia coli (strain K12) manY gene Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 101000686777 Escherichia phage T7 T7 RNA polymerase Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 description 1
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 description 1
- 101150013996 LIP gene Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 101100278084 Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) dnaK1 gene Proteins 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710149951 Protein Tat Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010091732 SEC Translocation Channels Proteins 0.000 description 1
- 102000018673 SEC Translocation Channels Human genes 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 101100322791 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ago1 gene Proteins 0.000 description 1
- 108091003202 SecA Proteins Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101100117145 Synechocystis sp. (strain PCC 6803 / Kazusa) dnaK2 gene Proteins 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 101710168651 Thioredoxin 1 Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102100039933 Ubiquilin-2 Human genes 0.000 description 1
- 101710173440 Ubiquilin-2 Proteins 0.000 description 1
- 101100128403 Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) hlyC gene Proteins 0.000 description 1
- 101150003160 X gene Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 101150055570 araR gene Proteins 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 101150052825 dnaK gene Proteins 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 101150091094 lipA gene Proteins 0.000 description 1
- 101150056138 lipA1 gene Proteins 0.000 description 1
- 101150114896 lipA2 gene Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 101150044611 pel gene Proteins 0.000 description 1
- 101150107164 phoD gene Proteins 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940124551 recombinant vaccine Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 101150118060 trxA gene Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711494578.7A CN109988802B (zh) | 2017-12-31 | 2017-12-31 | 一种高效分泌表达人源fgf21蛋白的表达盒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711494578.7A CN109988802B (zh) | 2017-12-31 | 2017-12-31 | 一种高效分泌表达人源fgf21蛋白的表达盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109988802A CN109988802A (zh) | 2019-07-09 |
CN109988802B true CN109988802B (zh) | 2021-12-10 |
Family
ID=67110738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711494578.7A Active CN109988802B (zh) | 2017-12-31 | 2017-12-31 | 一种高效分泌表达人源fgf21蛋白的表达盒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109988802B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110564662B (zh) * | 2019-09-30 | 2022-03-25 | 南京农业大学 | 一种整合型高效表达乙醛脱氢酶枯草杆菌的构建方法 |
CN110894504A (zh) * | 2019-12-20 | 2020-03-20 | 武汉茵慕生物科技有限公司 | 强化表达葡萄糖6-磷酸脱氢酶的地衣芽胞杆菌在异源蛋白生产中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101376888A (zh) * | 2008-09-28 | 2009-03-04 | 李校堃 | 一种分泌表达重组人成纤维细胞生长因子-21的生产方法 |
CN101781657A (zh) * | 2009-01-19 | 2010-07-21 | 中国人民解放军军事医学科学院军事兽医研究所 | 重组枯草芽孢杆菌分泌型表达载体 |
CN101967485A (zh) * | 2010-09-07 | 2011-02-09 | 东北农业大学 | 人fgf21突变基因及制备重组人fgf21蛋白方法 |
CN104031913A (zh) * | 2013-03-07 | 2014-09-10 | 华东理工大学 | 一种用于在枯草芽孢杆菌中分泌表达外源蛋白的表达设备 |
-
2017
- 2017-12-31 CN CN201711494578.7A patent/CN109988802B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101376888A (zh) * | 2008-09-28 | 2009-03-04 | 李校堃 | 一种分泌表达重组人成纤维细胞生长因子-21的生产方法 |
CN101781657A (zh) * | 2009-01-19 | 2010-07-21 | 中国人民解放军军事医学科学院军事兽医研究所 | 重组枯草芽孢杆菌分泌型表达载体 |
CN101967485A (zh) * | 2010-09-07 | 2011-02-09 | 东北农业大学 | 人fgf21突变基因及制备重组人fgf21蛋白方法 |
CN104031913A (zh) * | 2013-03-07 | 2014-09-10 | 华东理工大学 | 一种用于在枯草芽孢杆菌中分泌表达外源蛋白的表达设备 |
Non-Patent Citations (2)
Title |
---|
A Bicistronic Vector With Destabilized mRNA Secondary Structure Yields Scalable Higher Titer Expression of Human Neurturin in E. coli;Varnika Roy等;《Biotechnology and Bioengineering》;20170831;第114卷(第8期);第1753-1761页 * |
Translation of a synthetic two-cistron mRNA in Escherichia coli;B E Schoner等;《PNAS》;19861101;第83卷(第22期);第8507页图1,第8508页图4 * |
Also Published As
Publication number | Publication date |
---|---|
CN109988802A (zh) | 2019-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080076157A1 (en) | Signal peptide for the production of recombinant proteins | |
KR20070072831A (ko) | 탄저균의 포자외막 단백질을 이용한 목적단백질의 미생물표면발현방법 | |
CN109486847B (zh) | 基于人工串联启动子的枯草芽孢杆菌高效诱导表达系统 | |
CN109988802B (zh) | 一种高效分泌表达人源fgf21蛋白的表达盒及其应用 | |
AU2010283807B2 (en) | Vector comprising mannose promoter and mannose promoter | |
Reed et al. | Biotechnological applications of bacterial protein secretion: from therapeutics to biofuel production | |
KR20140004219A (ko) | 대장균에서 이형 단백질 생산을 위한 새로운 발현 및 분비 벡터 시스템 | |
AU2016256579B2 (en) | Uncoupling growth and protein production | |
CN112522285B (zh) | 一种温度控制表达系统与应用 | |
WO2017181920A1 (zh) | 一种重组人粒细胞集落刺激因子的制备方法 | |
EP3452496A1 (en) | Method of producing a recombinant protein | |
US20140154742A1 (en) | Novel expression and secretion vector systems for heterologous protein production in escherichia coli | |
US9157085B2 (en) | Expression vector for expression of eukaryotic secretion leader sequence fused with a target polypeptide and methods of use thereof | |
US20120196323A1 (en) | Fermentation Process | |
WO2019154311A1 (zh) | 一种密码子优化的人胰岛素类似物前体基因和信号肽基因 | |
Naderi et al. | Crucial role of non-hydrophobic residues in H-region signal peptide on secretory production of l-asparaginase II in Escherichia coli | |
CN112888787A (zh) | 新型细菌lpp突变体及其在重组蛋白质的分泌生产中的用途 | |
WO2010001960A1 (ja) | 組換えブレビバチルス属細菌による組換え蛋白質の製造方法 | |
CN1345370A (zh) | 宿主细胞中重组多肽的区室化 | |
US10273520B2 (en) | Means and methods for hyper-production of authentic human basic fibroblast growth factor in Escherichia coli | |
CN107857801B (zh) | 一种可用于提高分泌效率的信号肽及其应用 | |
KR101745588B1 (ko) | 주변세포질에 목적 단백질을 과량으로 분비발현할 수 있는 변이균주 | |
KR20040081237A (ko) | 봉입체 결합 단백질을 코딩하는 유전자를 결핍시키거나증폭시켜 목적 단백질을 제조하는 방법 | |
US20150037842A1 (en) | Modified bacterial cell | |
CN117402876A (zh) | 一种串联启动子、重组菌株及在重组大肠埃希菌寡糖合成中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190709 Assignee: Tianjin Chunyao Biotechnology Co.,Ltd. Assignor: TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES Contract record no.: X2023980036854 Denomination of invention: An efficient expression cassette for secreting and expressing human FGF21 protein and its application Granted publication date: 20211210 License type: Common License Record date: 20230620 |